SAGE DOW: Open Payments
NPI 1871009886 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,477 in 122 payments from 16 companies in 2025. Trend: 2023 $2,953 · 2024 $2,269 · 2025 $2,477
Food & beverage: $2,411Education: $66
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $511 |
| GENZYME CORPORATION | 9 | $326 |
| Janssen Biotech, Inc. | 13 | $313 |
| Incyte Corporation | 11 | $237 |
| Amgen Inc. | 7 | $224 |
| Regeneron Healthcare Solutions, Inc. | 9 | $171 |
| Lilly USA, LLC | 7 | $169 |
| Novartis Pharmaceuticals Corporation | 6 | $115 |
| PFIZER INC. | 4 | $88 |
| E.R. Squibb & Sons, L.L.C. | 3 | $80 |
Products named: DUPIXENT, TREMFYA, RINVOQ, OPZELURA, Otezla, SKYRIZI, TALTZ, CIBINQO.
Industry payments across MA — which companies pay providers there.
